71288-153 : Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution


NDC: 71288-153
Labeler: Meitheal Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Azacitidine
Dosage Form: Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
Application #: ANDA212128
Rev. Date: 


NDC Package Codes:

  • 71288-153-95: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (71288‑153‑95) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Azacitidine

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 71288-115 Azacitidine 100 mg/30ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc.
  • 0143-9606 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0591-2897 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
  • 0781-3253 Azacitidine 100 mg/1 Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
  • 0781-3491 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
  • 0781-9253 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
  • 13925-523 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Seton Pharmaceuticals
  • 16714-578 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 16714-777 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 16714-927 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 16729-306 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc.
  • 43598-143 Azacitidine 100 mg/50ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.
  • 43598-305 Azacitidine 100 mg/1 Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.
  • 43598-465 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.
  • 43817-906 Azacitidine 100 mg/50ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Panacea Biotec Ltd.
  • 51991-797 Azacitidine 100 mg/50ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Breckenridge Pharmaceutical, Inc.
  • 55150-393 Azacitidine 100 mg/4ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Eugia Us LLC
  • 60505-6271 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Apotex Corp
  • 63323-771 Azacitidine 100 mg/30ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 63759-0003 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Shilpa Medicare Limited
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71288-153 QR Code

< Prev: 71288-149Next: 71288-155 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.